#1
|
|||
|
|||
Àñïèðàöèÿ òðîìáà âî âðåìÿ ïåðâè÷íîé ÒÁÊÀ
Tone Svilaas, M.D. et al. Thrombus Aspiration during Primary Percutaneous Coronary Intervention. NEJM 2008 V. 358: 557-567
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Background Primary percutaneous coronary intervention (PCI) is effective in opening the infarct-related artery in patients with myocardial infarction with ST-segment elevation. However, the embolization of atherothrombotic debris induces microvascular obstruction and diminishes myocardial reperfusion. Methods We performed a randomized trial assessing whether manual aspiration was superior to conventional treatment during primary PCI. A total of 1071 patients were randomly assigned to the thrombus-aspiration group or the conventional-PCI group before undergoing coronary angiography. Aspiration was considered to be successful if there was histopathological evidence of atherothrombotic material. We assessed angiographic and electrocardiographic signs of myocardial reperfusion, as well as clinical outcome. The primary end point was a myocardial blush grade of 0 or 1 (defined as absent or minimal myocardial reperfusion, respectively). Results A myocardial blush grade of 0 or 1 occurred in 17.1% of the patients in the thrombus-aspiration group and in 26.3% of those in the conventional-PCI group (P<0.001). Complete resolution of ST-segment elevation occurred in 56.6% and 44.2% of patients, respectively (P<0.001). The benefit did not show heterogeneity among the baseline levels of the prespecified covariates. At 30 days, the rate of death in patients with a myocardial blush grade of 0 or 1, 2, and 3 was 5.2%, 2.9%, and 1.0%, respectively (P=0.003), and the rate of adverse events was 14.1%, 8.8%, and 4.2%, respectively (P<0.001). Histopathological examination confirmed successful aspiration in 72.9% of patients. Conclusions Thrombus aspiration is applicable in a large majority of patients with myocardial infarction with ST-segment elevation, and it results in better reperfusion and clinical outcomes than conventional PCI, irrespective of clinical and angiographic characteristics at baseline. (Current Controlled Trials number, ISRCTN16716833 [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] .) |
#2
|
||||
|
||||
Èíòåðåñåí îòå÷åñòâåííûé îïûò àñïèðàöèîííîé òðîìáýêòîìèè èç êîðîíàðíûõ àðòåðèé.  ïåðâóþ î÷åðåäü - êàêèìè àñïèðàöèîííûìè êàòåòåðàìè ïîëüçóþòñÿ êîëëåãè? Íó è, åñòåñòâåííî, ðåçóëüòàòû...
|
#3
|
||||
|
||||
Íàñêîëüêî ÿ çíàþ, ïðèëè÷íûé è âåñüìà ïîëîæèòåëüíûé îïûò òðîìáýêòîìèè, èìååò ÄðÑåðã. Ñåðåãà, îòêëèêíèñü!
__________________
Àáóãîâ Ñåðãåé Àëåêñàíäðîâè÷. Ðîññèéñêèé Íàó÷íûé Öåíòð Õèðóðãèè èì. àêàäåìèêà Á.Â. Ïåòðîâñêîãî. |
#4
|
||||
|
||||
Îïûò íå î÷åíü áîëüøîé - íå áîëåå äåñÿòè áîëüíûõ.
Âî âñåõ ñëó÷àÿõ ðàáîòàëè íà ñâåæåì èíôàðêòå ñ ÿâíûìè àíãèîãðàôè÷åñêèìè ïðèçíàêàìè òðîìáîòè÷åñêîé îêêëþçèè. Êàòåòåð - DIVER (Invatec). Ïîñëå àñïèðàöèè âîññòàíàâëèâàëñÿ àäåêâàòíûé êðîâîòîê ïî àðòåðèè (íå ìåíåå TIMI2), äàëåå ïðÿìîå ñòåíòèðîâàíèå.  òðåõ ñëó÷àÿõ íè÷åãî íå àñïèðèðîâàëîñü. Âî âñåõ ñëó÷àÿõ "no reflow" íå áûëî. Àíãèîãðàììû ñäåëàþ ïîçæå. Ïàðà ôîòîê àñïèðèðîâàííûõ òðîìáîâ. |
#5
|
||||
|
||||
Ýòî òîò, êîòîðûé Diver CE?  òåõ ñëó÷àÿõ, êîãäà íèñåãî íå óäàâàëîñü àñïèðèðîâàòü, óäàâàëàñü ëè ìåõàíè÷åñêàÿ ðåêàíàëèçàöèÿ? Êàêèå îùóùåíèÿ?
|
#6
|
|||
|
|||
Ïîëüçóåìñÿ àñïèðàöèîííûìè êàòåòåðàìè QuickCat (Kensey Nash), âïå÷àòëåíèÿ òîëüêî ïîëîæèòåëüíûå.
Ñåãîäíÿøíèé ïðèìåð: Æ. òðîìáîòè÷åñêàÿ îêêëþçèÿ ÏÊÀ: [Èçîáðàæåíèÿ äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì] [Èçîáðàæåíèÿ äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì] [Èçîáðàæåíèÿ äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì] P.S. óñòðîéñòâî èñïîëüçóåòñÿ ïî óñìîòðåíèþ îïåðàòîðà |
#7
|
|||
|
|||
Ïðèìåð àñïèðàöèè íåñêîëüêî èíîãî ðîäà
![]() Ì. ñ òðîìáîòè÷åñêîé îêêëþçèåé ÏÊÀ, ïîñëå ïðÿìîãî ñòåíòèðîâàíèÿ ôðàãìåíò òðîìáà îêàçàëñÿ ïðîêñèìàëüíåå ñòåíòà (òî ëè îïåðàòîð "ïðîìàçàë", òî ëè ýôôåêò "ñíåæíîãî êîìêà"...), ôðàãìåíò óñïåøíî àñïèðèðîâàí ïðîâîäíèêîâûì êàòåòåðîì (6F) ñ èñïîëüçîâàíèåì îáû÷íîãî 20 ìë. øïðèöà. [Èçîáðàæåíèÿ äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì] [Èçîáðàæåíèÿ äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì] [Èçîáðàæåíèÿ äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì] |
#8
|
|||
|
|||
Óâàæàåìûé Sergnt,
Îïóáëèêîâàííû äàííûå èññëåäîâàíèÿ TAPAS (êîòîðîå óïîìèíàëîñü âûøå) çà ãîä. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study Åñëè Âàñ èíòåðåñóåò ïîëíàÿ âåðñèÿ èç Ëàíöåòà, ÿ Âàì ñðàçó åå âûøëþ. |
#9
|
|||
|
|||
|
#10
|
|||
|
|||
Öèòàòà:
|
#11
|
|||
|
|||
|